| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $11.7B | $9.2B | $5.9B | $4.0B | $1.8B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | $2.0B | $1.8B | — | — | — |
| Operating Income | $-0.4B | $0.1B | $-0.2B | $-0.6B | $-0.5B |
| Net Income | $-0.4B | $0.0B | $-0.3B | $-0.6B | $-0.6B |
| EPS (Basic) | $-1.69 | $0.11 | $-1.22 | $-2.85 | $-3.20 |
| EPS (Diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $6.3B | $4.8B | $3.6B | $4.5B | $3.3B |
| Current Assets | $4.6B | $2.8B | $3.1B | $4.1B | $2.3B |
| Cash & Equivalents | $2.8B | $1.5B | $1.9B | $1.6B | $1.1B |
| Total Liabilities | $5.3B | $3.8B | $2.8B | $3.6B | $1.9B |
| Current Liabilities | $4.9B | $3.5B | $2.4B | $3.3B | $1.9B |
| Stockholders' Equity | $1.0B | $1.0B | $0.8B | $0.9B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.0B | $-0.3B | $0.4B | $-0.2B |
| Investing Cash Flow | $-0.2B | $-1.4B | $0.6B | $-0.2B | $-0.8B |
| Capital Expenditures | — | — | — | — | — |
| Financing Cash Flow | $0.4B | $0.1B | $0.0B | $0.3B | $1.2B |